MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » GI Dynamics touts no complications, lowered insulin in EndoBarrier reimplantation trial

GI Dynamics touts no complications, lowered insulin in EndoBarrier reimplantation trial

By

GI Dynamics

GI Dynamics (ASX:GID) today released data from an investigator-initiated study examining the safety and efficacy of its EndoBarrier after reimplantation for treatment for patients with type 2 diabetes and obesity, touting no complications and reduced insulin use.

The study followed 5 patients which all completed an initial course of EndoBarrier treatment for 12 months, after which the devices were explanted and patients were monitored for 4 months, after which the device was reimplanted for another 12 months.

Data from the trial indicated no complications and showed reductions in HbA1c levels and insulin during both implantation periods. HbA1c fell from a baseline of 9.1% to 6.7% after the 1st explant, and from 7.8% upon 2nd implantation to 7.1% upon the 2nd explant, the company said.

Insulin usage fell from a baseline of 60iU to 19iU at the 1st explant, and from 33iU to 20iU on the second round of implanting and explanting of the device, according to GI Dynamics.

“Although small, this study provided important information regarding serial usage of EndoBarrier. Re-implantation and re-explantation of the EndoBarrier device were performed on all five study subjects without any complications, and the early clinical data is promising. In addition, there was a significant reduction in insulin,” study primary investigator Dr. Jurgen Stein said in a prepared statement.

“The study shows early indication of efficacy to support multiple treatments utilizing EndoBarrier. Especially encouraging is the reduction of blood sugar and weight combined with concurrent reduction in insulin. We appreciate Dr. Stein’s efforts to conduct a study that adds such interesting insights into the growing body of evidence proving EndoBarrier safety and efficacy,” CEO & prez Scott Schorer said in a press release.

Last month, GI Dynamics released data from a meta-analysis of its EndoBarrier device, touting improved glycemic control in patients with type 2 diabetes and obesity. Data from the meta-analysis study was presented at the Digestive Disease Week meeting in Chicago.

In case you missed it

RSS From Medical Design & Outsourcing

  • XL Precision Technologies plans UK, U.S. expansions
    XL Precision Technologies (XL-PT) has announced a major capital investment to expand facilities in the first quarter of 2021. At the primary manufacturing site in Stockton-on-Tees (UK), XL-PT has signed the lease to the adjacent building, which will add 17,400 ft2 of floor space to the existing capacity. Occupancy is expected within three months. XL-PT… […]
  • Researchers tout biomaterials that can be ‘fine-tuned’ for medtech
    Researchers in the UK and U.S. are touting a new thermoplastic biomaterial capable of “fine-tuning” for use in soft tissue repair or bioelectronics. According to a news release, the material, which is a type of polyester, has been developed by a team at the University of Birmingham (UK) and Duke University (U.S.) for use in… […]
  • HHS could make permanent pandemic-related exemptions for some devices
    HHS has used the Trump administration’s waning days to propose permanently exempting certain medical devices — including infusion pump controllers and fetal monitors — from the FDA 510(k) clearance process. In a notice published Jan. 15, 2021, in the Federal Register, the agency also listed seven types of patient examination gloves that it has decided… […]
  • Medtechs can’t set digital strategies aside – DTW Podcast
    Digital connectivity no longer belongs in the final slides of a medtech company’s pitch deck. In the latest DeviceTalks Weekly podcast, three leaders pushing for connected medical devices explain the need to incorporate data collection and monitoring functionality in new devices: Scott Huennekens, who advanced the “digital surgery” strategy when he helped launch Verb Surgical,… […]
  • Protolabs to acquire 3D Hubs for up to $330M
    Protolabs (NYSE: PRLB) today announced it plans to acquire Amsterdam-based 3D Hubs, an online manufacturing platform that provides engineers with on-demand access to a global network of approximately 240 manufacturing partners. The transaction creates a comprehensive digital manufacturing offer for custom parts, expanding Protolabs’ breadth of capabilities as well as adding a broader offering of pricing and… […]
  • These medtech stocks performed the best in 2020
    While 2020 did not go as planned for anyone, with the twists and turns came opportunities for medtech companies to power forward. Innovations came both as a result of the COVID-19 pandemic and perhaps in spite of the challenges brought on by the virus, highlighted by the increased efforts to produce vaccines and testing while… […]
  • Covestro tests plastics against high-strength hospital disinfectants
    Covestro announced that it recently teamed with disinfectant manufacturer Metrex to test five different Covestro polycarbonate materials against three of Metrex’s products, which are widely used throughout the healthcare industry. As is customary for rapidly assessing the compatibility of plastics to disinfectants, test specimens were pre-strained and underwent several wipe-and-dry cycles with Metrex disinfectants to… […]
  • Integer expands N.Y. battery plant
    Integer announced today that it recently broke ground on an expansion of its Alden, N.Y., facility to accommodate new equipment that will substantially increase the plant’s production capacity for rechargeable Xcellion lithium-ion batteries. The project kicked off in mid-December 2020 and will add both production equipment and a build-out of Integer’s existing facility. The company… […]
  • Diversified Plastics adds high-efficiency vertical presses
    Diversified Plastics (DPI) announced that it recently installed six all-electric vertical injection molding presses. These presses will join DPI’s existing assemblage of vertical presses and provide increased production capacity to meet growing demand from medical device and other original equipment manufacturers (OEMs). DPI uses vertical presses for over-molding and insert-molding, capabilities often required for medical… […]
  • Traco Power expands power supply line for portable medical equipment
    Traco Power announced that it has expanded its TPP 450 high-density 3×5 power supply series. The series now offers Protection Class II models (TPP 450BA-M Open-Frame Models and TPP 450B-M Enclosed with Fan Models), designed for non-stationary requirements where connection to ground is not possible. Key approvals on the original series remain on the expanded… […]
  • Reflow Medical launches low-profile reinforced support catheters
    Reflow Medical today announced it has launched its Reflow Spex Low Profile reinforced support catheters. The Spex LP catheters are designed to provide the lowest profile tip to access and cross the tightest and most complex lesions with a supportive system. They come in 0.014 in. and 0.018 in. sizes and can be combined with… […]